# Quetiapine in Co-Morbid Depressive and Anxiety Disorders

> **NCT00688818** · NA · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 108 (actual)

## Conditions studied

- Major Depressive Disorder
- Dysthymic Disorder
- Anxiety Disorders
- Generalized Anxiety Disorder
- Social Anxiety Disorder
- Panic Disorder
- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** Quetiapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00688818
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688818, "Quetiapine in Co-Morbid Depressive and Anxiety Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00688818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*